Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics. Geneoscopy’s lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designation from the FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Our initial prospective clinical study demonstrates that the diagnostic can detect these lesions with greater sensitivity than all existing noninvasive screening tests, thereby, serve as a potential aid in early detection and prevention of cancer. Geneoscopy is also developing diagnostics for the diagnosis and management of inflammatory bowel disease in partnership with biopharmaceutical companies and leading academic research institutions. 

Missouri Technology Corporation

Dorm Room Fund

NT Asset

Cultivation Capital

Lightchain

Rodger Riney

BioGenerator

Innovatus Capital Partners

NT Investments

LabCorp

Morningside Venture Investments

Morningside Ventures

Geneoscopy

Exact Sciences Corporation is a molecular diagnostics company that focuses on the early detection and prevention of colorectal cancer. It is known for its Cologuard test, a non-invasive screening option for colorectal cancer.

Exact Sciences Corporation

Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company offers a range of products and services related to genomic cancer screening.

Qiagen

EDP Biotech is an in vitro diagnostics laboratory that offers a reference laboratory and CRO services for various diseases, including cancer. The company is involved in the development and provision of diagnostic tests for cancer screening.

EDP Biotech

Geneoscopy is a molecular diagnostics company that develops non-invasive tests for the early detection of diseases such as colorectal cancer. The company leverages genomic technology to analyze patient samples, aiming to improve screening compliance and patient outcomes.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 15, 2024 6:05 AM	fd3351c8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	f89f67c1
crunchbase profile	general
li profile	general	May 15, 2024 6:05 AM	b134b220
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:GENEOSCOPY

Geneoscopy